Multi-Session Radiosurgery for Numerous Small Brain Metastases
Objectives: Treatment of multiple brain metastases more than 10 is challenging. Whole brain radiotherapy (WBRT) is generally believed to be the first treatment choice. In order to escape from mental deterioration after WBRT, we have performed Gamma Knife stereotactic radiosurgery (GKS) for numerous small brain metastases.
Methods: Twelve cases of numerous (more than 30) brain metastases were treated by GKS. Mean total session number was 5.42 times, ranging 2 to 17. Each tumor was treated with the margin dose between 14 to 20 Gy. The tumor number treated in whole sessions was ranged from 31 to 144 (mean, 70.8).
Results: Almost all the irradiated tumors either disappeared or shrank at the patient’s death or at the last follow-up, though new metastatic tumors were subsequently developed in some cases which required an additional treatment with GKS. At the last follow-up (3 to 51 months after GKS), nine cases were alive and well and three were dead. As adverse effects, two cases demonstrated seizures by radiation brain injury and another showed a gait disturbance. No apparent mental deterioration was observed during follow-up.
Conclusion: Radiosurgery for numerous small brain metastases may be preferable rather than WBRT.
1. Shuto T, Akabane A, Yamamoto M, Serizawa T, Higuchi Y, Sato Y, et al. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC). J Neurosurg 2018;129:86–94. [CrossRef]
2. Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J. et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 2014;15:387– 95. [CrossRef]
3. Yamashita K, Kuwashiro T, Ishikawa K, Furuya K, Harada S, Shin S, et al. Identification of predictors for mini-mental state examination and revised Hasegawa's Dementia Scale scores using MR-based brain morphometry. Eur J Radiol Open 2021;8:100359. [CrossRef]
4. Shuto T, Fujino H, Inomori S, Nagano H. Repeated gamma knife radiosurgery for multiple metastatic brain tumours. Acta Neurochir (Wien) 2004;146:989–93. [CrossRef]
5. Morrison J, Hood R, Yin FF, Salama JK, Kirkpatrik J, Adamson J. Is a single isocenter sufficient for volumetric modulated arc therapy radiosurgery when multiple intracranial metastases are spatially dispersed? Med Dosim 2016;41:285–9. [CrossRef]
6. Niranjan A, Monaco E, Flickinger J, Lunsford LD. Guidelines for multiple brain metastases radiosurgery. Prog Neurol Surg 2019;34:100–9. [CrossRef]
7. Nguyen TK, Sahgal A, Detsky J, Soliman H, Myrehaug S, Tseng C-L, et al. Single-fraction stereotactic radiosurgery versus hippocampal-avoidance whole brain radiation therapy for patients with 10 to 30 brain metastases: A dosimetric analysis.
Int J Radiot Oncol Biol Phys 2019;105:394–9. [CrossRef]
8. Knoll MA, Oermann EK, Yang AI, PaydarI, Steinberger J, Collins B, et al. Survival of patients with multiple intracranial metastases treated with stereotactic radiosurgery; Does the number of tumors matter? Am J Clin Oncol 2018;41:425–31. [CrossRef]
9. Kida Y, Mori Y. Radiosurgery for patients with more than ten brain metastases. Cureus 2020;12:6728. [CrossRef]
10. Yamamoto M, Kawabe T, Barfod B. How many metastases can be treated with radiosurgery. Prog Neurological Surgery 2012;25:261–72. [CrossRef]
11. Rush S, Elliott R, Morsi A, Mehta N, Spriet J, Narayana A, et al. Incidence, timing, and treatment of new brain metastases after gamma knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy. J Neurosurg 2011;115:37–48. [CrossRef]
12. Yamamoto M, Ide M, Nishio S, Urakawa Y. Gamma knife radiosurgery for numerous brain metastases: is this a safe treatment?. Int J Radiol Oncol Biol Phys 2002;53:1279–83. [CrossRef]
13. Arvanitis CD, Ferrano G, Jain R. The blood-brain barrier and blood-tumor barrier in brain tumours and metastases. Nat Rev Cancer 2020;20:26–41. [CrossRef]
14. Dumoulin J, Rozensztajn N, Paradia M, Sellier J, Abel A, Giraud P, et al. Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma. Rev Mal Respir 2016;33:67–71. [CrossRef]
15. Sekine A, Kano T, Hagiwara E, Shinohara T, Komagata T,Iwasawa T, et al. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer 2012;77:64–9. [CrossRef]
16. Kurihara M, Koda H, Aono H, Sugimoto I, Sakurai Y, Sano T, et al. Rapidly progressive miliary brain metastasis of lung cancer after EGFR tyrosine kinase inhibitor discontinuation: An autopsy report. Neuropathology 2019;39:147–55. [CrossRef]
17. Suh JH, Kotecha R, Chao ST, Ahluwalia MS, Sagal A, Chang EC. Current approaches to the management of brain metastases. Nat Rev Clin Oncol 2020;17:279–99. [CrossRef]
18. Kim M, Cho KR, Choi JW, Seol HJ, Nam DH, Lee JL. Two-staged gamma knife radiosurgery for treatment of numerous (>10) brain metastases. Clin Neurol Neurosurg 2020;195:105847.
19. Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL. Whole brain radiation therapy (WBRT) alone versus WBRT and radio surgery for the treatment of brain metastases. Cochrane Database Syst Rev 2012;12:CD006121. [CrossRef]